3D Cardiac Mapping Market by Application (Electro anatomical Mapping, Basket Catheter Mapping, and Real-Time Positional Management EP System) and End User (Hospitals, Clinics, and Diagnostics Centers): Opportunity Analysis and Industry Forecast, 2021-2027

ID: VPR/HC/109 Publishing Year: July 2020 Pages: 78 Format:   


Report Overview:

The 3D Cardiac Mapping Market is expected to register a CAGR of 10.8% from 2021 to 2027.

3D Cardiac Mapping is a process in which the information from cardiac electro grams is collected and displayed. 3D Cardiac Mapping used to diagnose heart rhythms especially in the case of Arrhythmia. It is a widely accepted technique for identification, characterization, and localization of an arrhythmia. It is a procedure which is commonly done by injecting catheter into the heart chamber to record electrograms sequentially. Advanced features offered by 3D cardiac mapping systems provide precise three-dimensional view of a cardiac chamber with a straightforward geometric display that has the ability to determine location and orientation of ablation catheter accurately.

The major features driving the growth of 3D Cardiac Mapping Market is the accuracy and patients safety enabled by real-time monitoring. In addition, Rise in the aging population leads to the chronic heart disorders which will result in the demand for the 3D Cardiac Mapping system are fueling the market growth. However, huge investment rate of services and lack of awareness about cardiac mapping technologies acts as hindrance for the growth of the market.

Segment Overview:

 The 3D Cardiac Mapping Market is segmented by Application, End User and Region.

Application Insights:

The Application Insight is segmented by electroanatomical mapping, basket catheter mapping, and real-time positional management EP system.With electroanatomical mapping, patients can get accurate and real-time picturing of cardiac anatomy. Furthermore, electro anatomical mapping is predicted to create newer opportunities for 3D Cardiac Mapping in the future.

End User Insights:

Based on End User Insights the 3D Cardiac Mapping Market is segmented by hospitals, clinics, and diagnostics centers. The hospitals section dominates the 3D Cardiac Mapping Market, and is expected to maintain its dominance throughout the forecast period.

Key Market Segments:

By Application

  • Electroanatomical Mapping
  • Basket Catheter Mapping 
  • Real-Time Positional Management EP System.

By End User

  • Hospitals
  • Clinics
  • Diagnostics

Based on Region:

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest Of APAC

Rest of the World

 



Frequently Asked Questions
The 3D Cardiac Mapping Market is growing at an Annual rate of 10.8%.
Medtronic, MicroPort Scientific Corporation, EP Solutions SA, Acutus Medical, Koninklijke Philips N.V., Lepu Medical , BIOTRONIK, AngioDynamics, BioSig Technologies, APPN Health, CoreMap, Kardium, Catheter Precision, and Epmap-System.
Hospitals
Accuracy and patients safety enabled by real-time monitoring are the major factors driving the growth of 3D Cardiac Mapping Market.
North America.

TABLE OF CONTENTS:

CHAPTER 1 MARKET INTRODUCTION

1.1. REPORT OVERVIEW

1.2. SCOPE OF THE STUDY

1.3. PRIMARY MARKET SEGMENTS

1.4. RESEARCH METHODOLOGY

CHAPTER 2 EXECUTIVE SUMMARY

2.1. C-LEVEL EXECUTIVE’S OVERVIEW AND PERSPECTIVES

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE

3.2. PRINCIPAL FINDINGS

3.2.1. Key investment pockets

3.2.2. Leading winning strategies

  3.2.3 Key Player Positioning

3.3. PORTERS FIVE FORCES OF COMPETITIVE ANALYSIS

 3.4. MARKET DYNAMICS

3.4.1. Drivers

3.4.2. Restraints

3.4.3. Opportunities

3.4.4. Impact Analysis

3.5. IMPACT OF COVID-19 ON THIS MARKET

CHAPTER 4 3D Cardiac Mapping Market, BY Application

4.1. SYNOPSIS

4.1.1. Market size and forecast

4.2. Electroanatomical mapping

4.2.1. Key market trends

4.2.2. Growth factors and opportunities

4.2.3. Market size and forecast

4.3. Basket catheter mapping

4.3.1. Key market trends

4.3.2. Growth factors and opportunities

4.3.3. Market size and forecast

4.4. Real-time positional management (cardiac pathways) EP system

4.4.1. Key market trends

4.4.2. Growth factors and opportunities

4.4.3. Market size and forecast

CHAPTER 5 3D Cardiac Mapping Market, BY End User

5.1. SYNOPSIS

5.1.1. Market size and forecast

5.2. Hospitals

5.2.1. Key market trends

5.2.2. Growth factors and opportunities

5.2.3. Market size and forecast

5.3. Clinics

5.3.1. Key market trends

5.3.2. Growth factors and opportunities

5.3.3. Market size and forecast

5.4. Diagnostics Centre

5.4.1. Key market trends

5.4.2. Growth factors and opportunities

5.4.3. Market size and forecast

CHAPTER 6 3D Cardiac Mapping Market, BY REGION

6.1 SYNOPSIS

  6.1.1. Market size and forecast

6.2 North America

6.2.1 Key market trends

6.2.2 Competitive scenario

6.2.3 Key growth factors and opportunities

6.2.4 Market size and forecast

6.3 Europe

6.3.1 Key market trends

6.3.2 Competitive scenario

6.3.3 Key growth factors and opportunities

6.3.4 Market size and forecast

6.4 Asia Pacific

6.4.1 Key market trends

8.4.2 Competitive scenario

8.4.3 Key growth factors and opportunities

8.4.4 Market size and forecast

6.5 LAMEA

6.5.1 Key market trends

6.5.2 Key growth factors and opportunities

6.5.3 Market size and forecast

CHAPTER 7 COMPANY PROFILES

7.1.Medtronic (Ireland)

7.1.1. Company overview

7.2.2. Company snapshot

7.1.3. Product portfolio

7.1.4. Business performance

7.1.5. Key strategic moves and developments

7.2MicroPort Scientific Corporation (China)

7.2.1. Company overview

7.2.2. Company snapshot

7.2.3. Operating business segments

7.2.4. Product portfolio

7.2.5. Business performance

7.2.6. Key strategic moves and developments

7.3.EP Solutions SA (Switzerland)

7.3.1. Company overview

7.3.2. Company snapshot

7.3.3. Operating business segments

7.3.4. Product portfolio

7.3.5. Business performance

7.3.6. Key strategic moves and developments

7.4. Acutus Medical (US)

7.4.1. Company overview

7.4.2. Company snapshot

7.4.3. Operating business segments

7.4.4. Product portfolio

7.4.5. Business performance

7.4.6. Key strategic moves and developments

7.5.Koninklijke Philips N.V. (Royal Philips) (Netherlands)

7.5.1. Company overview

7.5.2. Company snapshot

7.5.3. Operating business segments

7.5.4. Product portfolio

7.5.5. Business performance

7.5.6. Key strategic moves and developments

7.6.Lepu Medical (China)

7.6.1. Company overview

7.6.2. Company Snapshot

7.6.3. Operating business segments

7.6.4. Product portfolio

7.6.5. Business performance

7.6.6. Key strategic moves and developments

7.7. BIOTRONIK (Germany)

7.7.1. Company overview

7.7.2. Company snapshot

7.7.3. Operating business segments

7.7.4. Product portfolio

7.7.5. Business performance

7.7.6. Key strategic moves and developments

7.8. AngioDynamics (US)

7.8.1. Company overview

7.8.2. Company snapshot

7.8.3. Operating business segments

7.8.4. Product portfolio

7.8.5. Business performance

7.8.6. Key strategic moves and developments

  7.9. BioSig Technologies (US)

7.9.1. Company overview

7.9.2. Company snapshot

7.9.3. Operating business segments

7.9.4. Product portfolio

7.9.5. Business performance

7.9.6. Key strategic moves and developments

  7.10. APPN Health (US)

7.10.1. Company overview

7.10.2. Company snapshot

7.10.3. Operating business segments

7.10.4. Product portfolio

7.10.5. Business performance

7.10.6. Key strategic moves and developments

  7.11. CoreMap (US)

7.11.1. Company overview

7.11.2. Company snapshot

7.11.3. Operating business segments

7.11.4. Product portfolio

7.11.5. Business performance

7.11.6. Key strategic moves and developments

  7.12. Kardium (Canada)

7.12.1. Company overview

7.12.2. Company snapshot

7.12.3. Operating business segments

7.12.4. Product portfolio

7.12.5. Business performance

7.12.6. Key strategic moves and developments

  7.13. Epmap-System (Germany).

7.13.1. Company overview

7.13.2. Company snapshot

7.13.3. Operating business segments

7.13.4. Product portfolio

7.13.5. Business performance

7.13.6. Key strategic moves and developments

  7.14. Catheter Precision (US)

7.14.1. Company overview

7.14.2. Company snapshot

7.14.3. Operating business segments

7.14.4. Product portfolio

7.14.5. Business performance

7.14.6. Key strategic moves and development

Type Here for figure.


PURCHASE OPTIONS




    ADD TO CART

CONTACT US
CALL US ON
( +91-9359194956 )

CONTACT EMAIL
[email protected]
PURCHASE OPTIONS




    ADD TO CART

CONTACT US
CALL US ON
( +91-9359194956 )

CONTACT EMAIL
[email protected]